142 related articles for article (PubMed ID: 8185133)
1. Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease.
Rader DJ; Hoeg JM; Brewer HB
Ann Intern Med; 1994 Jun; 120(12):1012-25. PubMed ID: 8185133
[TBL] [Abstract][Full Text] [Related]
2. Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease.
Genest JJ; Bard JM; Fruchart JC; Ordovas JM; Wilson PF; Schaefer EJ
Atherosclerosis; 1991 Oct; 90(2-3):149-57. PubMed ID: 1684707
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.
Sandholzer C; Boerwinkle E; Saha N; Tong MC; Utermann G
J Clin Invest; 1992 Mar; 89(3):1040-6. PubMed ID: 1541665
[TBL] [Abstract][Full Text] [Related]
4. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
Zambon A; Brown BG; Deeb SS; Brunzell JD
J Intern Med; 2006 May; 259(5):473-80. PubMed ID: 16629853
[TBL] [Abstract][Full Text] [Related]
5. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
Tsimikas S; Brilakis ES; Miller ER; McConnell JP; Lennon RJ; Kornman KS; Witztum JL; Berger PB
N Engl J Med; 2005 Jul; 353(1):46-57. PubMed ID: 16000355
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein(a) and apolipoproteins B and A-1 in children and coronary vascular events in their grandparents.
Wilcken DE; Wang XL; Greenwood J; Lynch J
J Pediatr; 1993 Oct; 123(4):519-26. PubMed ID: 8410502
[TBL] [Abstract][Full Text] [Related]
7. Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease.
Schaefer EJ; Heaton WH; Wetzel MG; Brewer HB
Arteriosclerosis; 1982; 2(1):16-26. PubMed ID: 6800349
[TBL] [Abstract][Full Text] [Related]
8. Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.
Kim HK; Chang SA; Choi EK; Kim YJ; Kim HS; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
Int J Cardiol; 2005 Jun; 101(3):435-40. PubMed ID: 15907412
[TBL] [Abstract][Full Text] [Related]
9. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants.
Wild SH; Fortmann SP; Marcovina SM
Arterioscler Thromb Vasc Biol; 1997 Feb; 17(2):239-45. PubMed ID: 9081676
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men.
Sigurdsson G; Baldursdottir A; Sigvaldason H; Agnarsson U; Thorgeirsson G; Sigfusson N
Am J Cardiol; 1992 May; 69(16):1251-4. PubMed ID: 1585854
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
Sharma R; Mahajan M; Singh B; Bal BS; Kant R
J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
[TBL] [Abstract][Full Text] [Related]
12. High density lipoproteins, reverse transport of cholesterol, and coronary artery disease. Insights from mutations.
Assmann G; von Eckardstein A; Funke H
Circulation; 1993 Apr; 87(4 Suppl):III28-34. PubMed ID: 8462178
[TBL] [Abstract][Full Text] [Related]
13. Evidence that apolipoprotein(a) phenotype is a risk factor for coronary artery disease in men < 55 years of age.
Parlavecchia M; Pancaldi A; Taramelli R; Valsania P; Galli L; Pozza G; Chierchia S; Ruotolo G
Am J Cardiol; 1994 Aug; 74(4):346-51. PubMed ID: 8059696
[TBL] [Abstract][Full Text] [Related]
14. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein(a) plasma concentrations, apolipoprotein (a) polymorphism and family history of coronary heart disease in patients with essential hypertension.
Gazzaruso C; Buscaglia P; Garzaniti A; Bonetti G; Savino S; Mariotti S; Jucci A; Finardi G; Geroldi D
J Cardiovasc Risk; 1996 Apr; 3(2):191-7. PubMed ID: 8836862
[TBL] [Abstract][Full Text] [Related]
16. Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion.
Mendoza SG; Zerpa A; Carrasco H; Colmenares O; Rangel A; Gartside PS; Kashyap ML
Artery; 1983; 12(1):1-23. PubMed ID: 6431945
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A-I and apolipoprotein B containing lipoprotein particles in coronary patients treated with extracorporal low density lipoprotein precipitation (HELP).
Koren E; Armstrong VW; Mueller G; Wilson PR; Schuff-Werner P; Thiery J; Eisenhauer T; Alaupovic P; Seidel D
Atherosclerosis; 1992 Aug; 95(2-3):157-70. PubMed ID: 1418090
[TBL] [Abstract][Full Text] [Related]
18. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
Kempen HJ; van Gent CM; Buytenhek R; Buis B
J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
[TBL] [Abstract][Full Text] [Related]
19. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
Hartgens F; Rietjens G; Keizer HA; Kuipers H; Wolffenbuttel BH
Br J Sports Med; 2004 Jun; 38(3):253-9. PubMed ID: 15155420
[TBL] [Abstract][Full Text] [Related]
20. The Apo A, B, a of coronary risk: back to kindergarten.
Wilcken DE; Wang XL; Dudman NP
Aust N Z J Med; 1992 Oct; 22(5 Suppl):570-5. PubMed ID: 1449441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
